Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis.

When adjusting for CUETO predictors, as well as for CUETO plus re-TUR, we did not find a statistically significant difference among the three strains in time to progression, but a trend towards significance was observed for TICE and RIVM compared to Connaught (HR 0.62, 95% CI 0.36–1.1 and 0.65, 95% CI 0.40–1.04 respectively; Supplementary Tables 2b–3b).

also in 2,760 other papers